Xilio Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2020 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Xilio Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
  • Xilio Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.22 USD/shares, a 63.9% increase year-over-year.
  • Xilio Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -1.72 USD/shares, a 41.9% increase year-over-year.
  • Xilio Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -2.78 USD/shares, a 13.7% increase from 2022.
  • Xilio Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -3.22 USD/shares, a 76.2% increase from 2021.
  • Xilio Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -13.5 USD/shares, a 87.2% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3 +$0.44 +13.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 -$3 +$10.30 +76.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 -$14 +$91.90 +87.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 -$105 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.